1.Determination of Aristolochic Acid Ⅰ and Aristolochic Acid Ⅱ in Human Serum by HPLC
China Pharmacy 2005;0(18):-
OBJECTIVE:To establish a HPLC method for the determination of aristolochic acidⅠand aristolochic acid Ⅱin human serum.METHODS:The separation was performed on C 18 column(250mm?4.6mm,5?m).The mobile phase consisted of methanol-water-acetic(72∶27∶1)at a flow rate of1.0ml/min.The detection wavelength was250nm.RESULTS:The linear ranges for aristolochic acidⅠand aristolochic acid Ⅱ were0.84~13.50?g/ml(r=0.9997,n=5)and2.03~32.50?g/ml(r=0.9994,n=5),respectively.The lowest determination concentration of aristolochic acid Ⅰ and aristolochic acid Ⅱ were0.3?g/ml and0.1?g/ml,respectively.CONCLUSION:The method is simple and practicable,and it can provide basis for clinical diagnosis and treatment of aristolochic acid nephropathy.
2.Determination of Serum Concentrations of Propofol by RP- HPLC
Shuomin JIANG ; Zengshou WANG ; Shengwei JIN
China Pharmacy 2001;12(3):161-162
OBJECTIVE: A RP- HPLC method was established for determination of serum concentration of propofol in man METHODS: The mobile phase consisted of methanol- water( 68∶ 32v/v) The detection was carried out at wave length 258nm and flow rate 1ml/min with carbamazepine as internal standard RESULTS: The retention times of propofol and carbamazepine were 9 20 and 5 16 min, respectively The mean recovery of propofol was 99% The within- day and inter- day variations were all less than 10% Propofol and carbamazepine were seperated well The assay linearity was obtained in the range of 1~ 16μ g/ml in serum( r=0 9 994) CONCLUSION: The method is sensitive, simple and reliable for the determination of propofol concentration
3.Pharmacokinetics of propofol in different age children after a single dose
Qingquan LIAN ; Wangning SHANGGUAN ; Zengshou WANG
Chinese Journal of Anesthesiology 1994;0(06):-
Objective To investigate the pharmacokinetics of propofol in children of different ages after a single dose. Methods Thirty-five ASA Ⅰ or Ⅱ children were divided into 3 age groups: group A
4.Determination of Serum Concentrations of Propofol by RP-HPLC
Shuomin JIANG ; Zengshou WANG ; Shengwei JIN
China Pharmacy 1991;0(03):-
OBJECTIVE:A RP-HPLC method was established for determination of serum concentration of propofol in man METHODS:The mobile phase consisted of methanol-water(68∶32v/v)The detection was carried out at wave length 258nm and flow rate 1ml/min with carbamazepine as internal standard RESULTS:The retention times of propofol and carbamazepine were 9 20 and 5 16 min,respectively The mean recovery of propofol was 99% The within-day and inter-day variations were all less than 10% Propofol and carbamazepine were seperated well The assay linearity was obtained in the range of 1~16?g/ml in serum(r=0 9 994) CONCLUSION:The method is sensitive,simple and reliable for the determination of propofol concentration
5.Content Determination of Clobetasol Propionate in Temeifu Pigmentum by UV Spectrophotometry
Peiying JI ; Zengshou WANG ; Guanghui ZHU
China Pharmacy 1991;0(02):-
OBJECTIVE:To establish a method for quick content determination of clobetasol propionate in temeifu pigmentum.METHODS:UV spectrophotometry was used,and the determination was performed at the wavelength of 240nm.RES-ULTS:The detectable concentration of clobetasol propionate have a good linear relationship with its absorbability in the range of 12~18?g/ml.The inter-day and intra-day average recoveries were 99.87%(RSD=1.21%) and 99.79%(RSD=1.01%),respectively.CONCLUSIONS:The present method is rapid and accurate,which can be widely used in small hospitals not equipped with high performance liquid chromatography.
6.A multicenter survey of the accessibility of essential medicines for children in China
Yi DAI ; Zhiping LI ; Hong XU ; Lin ZHU ; Yiqing ZHU ; Hua CHENG ; Zebin CHEN ; Qiangzeng HUANG ; Li LEI ; Renqiu LI ; Gen LI ; Yi LI ; Ming LIAO ; Qinghong LU ; Xiaoping SHI ; Huajun SUN ; Tianlu SHI ; Xuexin WU ; Zengshou WANG ; Jing XU ; Gan ZHAO ; Guying ZHANG ; Chao CHEN
Chinese Journal of Pediatrics 2020;58(4):301-307
Objective:To investigate the availability, prices and affordability of essential medicines in pediatric population across China, in the hope of improving rational use of medicines.Methods:A multicenter cross-sectional survey of medicine prices, availability and affordability was conducted in 17 provinces, municipalities and autonomous region across east, south-central part, west and north of China. Data on 42 medicines used in pediatric population, both original and generic, were collected in 55 public hospitals from May 26 to June 2, 2017. Availability was expressed as the percentage of hospitals with stock of the target medicine on the day of data collection,and median price ratio (MPR) was the ratio of price upon investigation to international reference. Based on national minimum daily wage, affordability represents the number of working days needed to earn the expense which covers a standard course using the target medicine. Statistical software SPSS 13.0 was applied for descriptive analysis of availability, MPR and affordability.Results:Mean Availability of original and generic medicine was 33% and 32%, with median MPR being 5.43 and 1.55. Among the 19 medicines with price information for both original and generic product, the median MPR was 7.73 and 2.04 respectively. Regarding the five medicines used to treat four common pediatric diseases (pneumonia,peptic ulcer, congenital hypothyroidism, refractory nephrotic syndrome), the affordability was 0.63 (0.16-6.17) d for generic medicine, and 1.03 (0.16-11.53) d for its original counterpart.Conclusions:The availability to both original and generic products of the 42 medicines used in pediatric population was low in China. The prices of generic medicines seem to be lower and affordability higher than those of original medicines. There is an urgent need to improve the availability and affordability of pediatric medicines.